EDGAR Filing Documents for 0001144204-13-019223

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:

SEC Accession No. 0001144204-13-019223

Filing Date

2013-04-01

Accepted

2013-04-01 16:48:15

Documents

Effectiveness Date

2013-04-01

Document Format Files

Seq	Description	Document	Type	Size
1	S-8 POS	v340048_s8pos.htm	S-8 POS	49481
2	EXHIBIT 5.1	v340048_ex5-1.htm	EX-5.1	8013
3	EXHIBIT 23.1	v340048_ex23-1.htm	EX-23.1	3462
	Complete submission text file	0001144204-13-019223.txt		61987

Mailing Address 33 HARBOUR SQ STE 202 TORONTO ONTARIO CA A1 M5J 2G2

Business Address 33 HARBOUR SQ STE 202 TORONTO ONTARIO CANADA A1 M5J 2G2 4163642551

GENEREX BIOTECHNOLOGY CORP (Filer) CIK: 0001059784 (see all company filings)